MedPath

PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION

PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION

Approved
DIN Number

02544857

Drug Class

Human

Market Date

N/A

Company
HC

dr reddy's laboratories ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02544857
AIG Number0110825002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01DB01 DOXORUBICIN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DOXORUBICIN HYDROCHLORIDEActive
Strength: 2 MG / ML
Monograph: DOXORUBICIN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.